|
1
|
Oliveira C, Seruca R and Carneiro F:
Hereditary gastric cancer. Best Pract Res Clin Gastroenterol.
23:147–157. 2009. View Article : Google Scholar
|
|
2
|
Cisco RM, Ford JM and Norton JA:
Hereditary diffuse gastric cancer: implications of genetic testing
for screening and prophylactic surgery. Cancer. 113:1850–1856.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fitzgerald RC, Hardwick R, Huntsman D,
Carneiro F, Guilford P, Blair V, Chung DC, Norton J, Ragunath K,
Van Krieken JH, et al: Hereditary diffuse gastric cancer: updated
consensus guidelines for clinical management and directions for
future research. International Gastric Cancer Linkage Consortium. J
Med Genet. 47:436–444. 2010. View Article : Google Scholar
|
|
4
|
Oliveira C, Bordin MC, Grehan N, Huntsman
D, Suriano G, Machado JC, Kiviluoto T, Aaltonen L, Jackson CE and
Caldas C: Screening E-cadherin in gastric cancer families reveals
germline mutations only in hereditary diffuse gastric cancer
kindred. Hum Mutat. 19:510–517. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ishii H, Ozawa K and Furukawa Y:
Alteration of the fragile histidine triad gene early in
carcinogenesis: an update. J Exp Ther Oncol. 3:291–296. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stec-Michalska K, Antoszczyk S, Klupinska
G and Nawrot B: Loss of FHIT expression in the gastric mucosa of
patients with family history of gastric cancer and Helicobacter
pylori infection. World J Gastroenterol. 11:17–21. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stec-Michalska K, Peczek L, Michalski B,
Wisniewska-Jarosinska M, Krakowiak A and Nawrot B: Helicobacter
pylori infection and family history of gastric cancer decrease
expression of FHIT tumor suppressor gene in gastric mucosa of
dyspeptic patients. Helicobacter. 14:126–134. 2009. View Article : Google Scholar
|
|
8
|
Baffa R, Veronese ML, Santoro R, Mandes B,
Palazzo JP, Rugge M, Santoro E, Croce CM and Huebner K: Loss of
FHIT expression in gastric carcinoma. Cancer Res. 58:4708–4714.
1998.PubMed/NCBI
|
|
9
|
Lee SH, Kim WH, Kim HK, Woo KM, Nam HS,
Kim HS, Kim JG and Cho MH: Altered expression of the fragile
histidine triad gene in primary gastric adenocarcinomas. Biochem
Biophys Res Commun. 284:850–855. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Weiske J and Huber O: The histidine triad
protein HINT1 triggers apoptosis independent of its enzymatic
activity. J Biol Chem. 281:27356–27366. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Su T, Suzui M, Wang L, Lin CS, Xing WQ and
Weinstein IB: Deletion of histidine triad nucleotide-binding
protein 1/PKC-interacting protein in mice enhances cell growth and
carcinogenesis. Proc Natl Acad Sci USA. 100:7824–7829. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang L, Zhang Y, Li H, Xu Z, Santella RM
and Weinstein IB: HINT1 inhibits growth and activator protein-1
activity in human colon cancer cells. Cancer Res. 67:4700–4708.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li H, Zhang Y, Su T, Santella RM and
Weinstein IB: HINT1 is a haplo-insufficient tumor suppressor in
mice. Oncogene. 25:713–721. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang YJ, Li H, Wu HC, Shen J, Wang L, Yu
MW, Lee PH, Weinstein IB and Santella RM: Silencing of HINT1, a
novel tumor suppressor gene, by promoter hypermethylation in
hepatocellular carcinoma. Cancer Lett. 275:277–284. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dixon MF, Genta RM, Yardley JH and Correa
P: Classification and grading of gastritis. The updated Sydney
System International Workshop on the Histopathology of Gastritis,
Houston 1994. Am J Surg Pathol. 20:1161–1181. 1996.PubMed/NCBI
|
|
16
|
Korsisaari N and Makela TP: Interactions
of Cdk7 and Kin28 with Hint/PKCI-1 and Hnt1 histidine triad
proteins. J Biol Chem. 275:34837–34840. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Weiske J and Huber O: The histidine triad
protein HINT1 interacts with Pontin and Reptin and inhibits
TCF-beta-catenin- mediated transcription. J Cell Sci.
118:3117–3129. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang L, Li H, Zhang Y, Santella RM and
Weinstein IB: HINT1 inhibits beta-catenin/TCF4, USF2 and NFkappaB
activity in human hepatoma cells. Int J Cancer. 124:1526–1534.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang H, Wei X, Su X, Qiao F, Xu Z, Gu D,
Fan H and Chen J: Clinical significance of expression of
Hint1 and potential epigenetic mechanism in gastric cancer.
Int J Oncol. 38:1557–1564. 2011.
|
|
20
|
Guranowski A, Wojdyła AM, Pietrowska-Borek
M, Bieganowski P, Khurs EN, Cliff MJ, Blackburn GM, Błaziak D and
Stec WJ: Fhit proteins can also recognize substrates other than
dinucleoside polyphosphates. FEBS Lett. 582:3152–3158. 2008.
View Article : Google Scholar
|
|
21
|
Stec-Michalska K: Clinical aspects of
changes of the level of expression of selected proapoptotic genes
in the gastric mucosa of patients with family history of gastric
cancer (habilitation dissertation). Medical University of Lodz;
Poland: 2010
|
